Lehman Ups NPS Pharmaceuticals to 'Overweight'

The drugmaker scrapped its plans to acquire Enzon Pharmeceuticals

Lehman Bros. upgraded NPS Pharmaceuticals (NPSP ) to overweight.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.